Episode 574
Will the U.S. Supreme Court be the Arbiter of Drug Safety? (Guest: Rik Mehta)
Health Care News Podcast · AnneMarie Schieber
April 26, 202315m 25s
Audio is streamed directly from the publisher (2.gum.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
How is it that Mifepristone was approved in the first place? The drug has high risk implications and because of that was authorized under a specific protocol that the Biden administration is now trying to change after the Dobb’s decision last year that reversed Roe v. Wade. Guest Rik Mehta comes onto the podcast to discuss the legal nature of it all.
Topics
Health CarePodcasts